A citation-based method for searching scientific literature

Dongling Liu, Xiang Zeng, Xiao Li, Jawahar L Mehta, Xianwei Wang. Basic Res Cardiol 2017
Times Cited: 160







List of co-cited articles
753 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mechanism and Regulation of NLRP3 Inflammasome Activation.
Yuan He, Hideki Hara, Gabriel Núñez. Trends Biochem Sci 2016
15

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
Paul M Ridker, Brendan M Everett, Tom Thuren, Jean G MacFadyen, William H Chang, Christie Ballantyne, Francisco Fonseca, Jose Nicolau, Wolfgang Koenig, Stefan D Anker,[...]. N Engl J Med 2017
13


The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation.
Nathan Kelley, Devon Jeltema, Yanhui Duan, Yuan He. Int J Mol Sci 2019
813
12

The NLRP3 inflammasome: molecular activation and regulation to therapeutics.
Karen V Swanson, Meng Deng, Jenny P-Y Ting. Nat Rev Immunol 2019
12

Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death.
Jianjin Shi, Yue Zhao, Kun Wang, Xuyan Shi, Yue Wang, Huanwei Huang, Yinghua Zhuang, Tao Cai, Fengchao Wang, Feng Shao. Nature 2015
12

Inflammasomes: mechanism of action, role in disease, and therapeutics.
Haitao Guo, Justin B Callaway, Jenny P-Y Ting. Nat Med 2015
11

The NLRP3 inflammasome in acute myocardial infarction.
Stefano Toldo, Antonio Abbate. Nat Rev Cardiol 2018
278
11

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.
Peter Duewell, Hajime Kono, Katey J Rayner, Cherilyn M Sirois, Gregory Vladimer, Franz G Bauernfeind, George S Abela, Luigi Franchi, Gabriel Nuñez, Max Schnurr,[...]. Nature 2010
11

The inflammasomes.
Kate Schroder, Jurg Tschopp. Cell 2010
10

The NLRP3 inflammasome: a sensor for metabolic danger?
Kate Schroder, Rongbin Zhou, Jurg Tschopp. Science 2010
763
10

K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter.
Raúl Muñoz-Planillo, Peter Kuffa, Giovanny Martínez-Colón, Brenna L Smith, Thekkelnaycke M Rajendiran, Gabriel Núñez. Immunity 2013
10

NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis.
Alena Grebe, Florian Hoss, Eicke Latz. Circ Res 2018
304
9

Activation and regulation of the inflammasomes.
Eicke Latz, T Sam Xiao, Andrea Stutz. Nat Rev Immunol 2013
9

Inflammasomes: mechanism of assembly, regulation and signalling.
Petr Broz, Vishva M Dixit. Nat Rev Immunol 2016
9

Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores.
Xing Liu, Zhibin Zhang, Jianbin Ruan, Youdong Pan, Venkat Giri Magupalli, Hao Wu, Judy Lieberman. Nature 2016
9

Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis.
Xianxian Wu, Haiying Zhang, Wei Qi, Ying Zhang, Jiamin Li, Zhange Li, Yuan Lin, Xue Bai, Xin Liu, Xiaohui Chen,[...]. Cell Death Dis 2018
215
9

Could NLRP3-Inflammasome Be a Cardiovascular Risk Biomarker in Acute Myocardial Infarction Patients?
Pedro Bullón, Francisco J Cano-García, Elísabet Alcocer-Gómez, Alfonso Varela-López, Lourdes Roman-Malo, Rafael J Ruiz-Salmerón, José L Quiles, José M Navarro-Pando, Maurizio Battino, Jesús Ruiz-Cabello,[...]. Antioxid Redox Signal 2017
28
28

Mechanisms and functions of inflammasomes.
Mohamed Lamkanfi, Vishva M Dixit. Cell 2014
8

A role for mitochondria in NLRP3 inflammasome activation.
Rongbin Zhou, Amir S Yazdi, Philippe Menu, Jürg Tschopp. Nature 2011
8

Targeting the NLRP3 inflammasome in inflammatory diseases.
Matthew S J Mangan, Edward J Olhava, William R Roush, H Martin Seidel, Gary D Glick, Eicke Latz. Nat Rev Drug Discov 2018
555
8

NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux.
Yuan He, Melody Y Zeng, Dahai Yang, Benny Motro, Gabriel Núñez. Nature 2016
560
8

NLRP3: A Novel Mediator in Cardiovascular Disease.
Wenyi Zhou, Chunyuan Chen, Zhiheng Chen, Lin Liu, Jie Jiang, Zhixiang Wu, Mingyi Zhao, Yanfang Chen. J Immunol Res 2018
103
8

The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP.
Geun-Shik Lee, Naeha Subramanian, Andrew I Kim, Ivona Aksentijevich, Raphaela Goldbach-Mansky, David B Sacks, Ronald N Germain, Daniel L Kastner, Jae Jin Chae. Nature 2012
585
8

The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance.
Bolormaa Vandanmagsar, Yun-Hee Youm, Anthony Ravussin, Jose E Galgani, Krisztian Stadler, Randall L Mynatt, Eric Ravussin, Jacqueline M Stephens, Vishwa Deep Dixit. Nat Med 2011
8

Pharmacological Inhibitors of the NLRP3 Inflammasome.
Ayesha Zahid, Bofeng Li, Arnaud John Kombe Kombe, Tengchuan Jin, Jinhui Tao. Front Immunol 2019
242
8

NLRP3 inflammasome and its inhibitors: a review.
Bo-Zong Shao, Zhe-Qi Xu, Bin-Ze Han, Ding-Feng Su, Chong Liu. Front Pharmacol 2015
413
7

NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy.
Beibei Luo, Feng Huang, Yanli Liu, Yiying Liang, Zhe Wei, Honghong Ke, Zhiyu Zeng, Weiqiang Huang, Yan He. Front Physiol 2017
99
7

Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension.
Shalini M Krishnan, Yeong H Ling, Brooke M Huuskes, Dorota M Ferens, Narbada Saini, Christopher T Chan, Henry Diep, Michelle M Kett, Chrishan S Samuel, Barbara K Kemp-Harper,[...]. Cardiovasc Res 2019
107
7

OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation.
Carlo Marchetti, Benjamin Swartzwelter, Fabia Gamboni, Charles P Neff, Katrin Richter, Tania Azam, Sonia Carta, Isak Tengesdal, Travis Nemkov, Angelo D'Alessandro,[...]. Proc Natl Acad Sci U S A 2018
200
7

A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.
Rebecca C Coll, Avril A B Robertson, Jae Jin Chae, Sarah C Higgins, Raúl Muñoz-Planillo, Marco C Inserra, Irina Vetter, Lara S Dungan, Brian G Monks, Andrea Stutz,[...]. Nat Med 2015
7

Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression.
Franz G Bauernfeind, Gabor Horvath, Andrea Stutz, Emad S Alnemri, Kelly MacDonald, David Speert, Teresa Fernandes-Alnemri, Jianghong Wu, Brian G Monks, Katherine A Fitzgerald,[...]. J Immunol 2009
7

NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.
Thomas van der Heijden, Eva Kritikou, Wouter Venema, Janine van Duijn, Peter J van Santbrink, Bram Slütter, Amanda C Foks, Ilze Bot, Johan Kuiper. Arterioscler Thromb Vasc Biol 2017
175
7

Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation.
Chunxia Yao, Tina Veleva, Larry Scott, Shuyi Cao, Luge Li, Gong Chen, Prince Jeyabal, Xiaolu Pan, Katherina M Alsina, Issam Abu-Taha,[...]. Circulation 2018
217
7

Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling.
Haitao Wen, Denis Gris, Yu Lei, Sushmita Jha, Lu Zhang, Max Tze-Han Huang, Willie June Brickey, Jenny P-Y Ting. Nat Immunol 2011
6

Thioredoxin-interacting protein links oxidative stress to inflammasome activation.
Rongbin Zhou, Aubry Tardivel, Bernard Thorens, Inpyo Choi, Jürg Tschopp. Nat Immunol 2010
6

NLRP3 inflammasome suppression improves longevity and prevents cardiac aging in male mice.
Fabiola Marín-Aguilar, Ana V Lechuga-Vieco, Elísabet Alcocer-Gómez, Beatriz Castejón-Vega, Javier Lucas, Carlos Garrido, Alejandro Peralta-Garcia, Antonio J Pérez-Pulido, Alfonso Varela-López, José L Quiles,[...]. Aging Cell 2020
62
9

NLRP3 inflammasomes show high expression in aorta of patients with atherosclerosis.
Fei Zheng, Shanshan Xing, Zushun Gong, Qichong Xing. Heart Lung Circ 2013
103
6

NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis.
Geena Paramel Varghese, Lasse Folkersen, Rona J Strawbridge, Bente Halvorsen, Arne Yndestad, Trine Ranheim, Kirsten Krohg-Sørensen, Mona Skjelland, Terje Espevik, Pål Aukrust,[...]. J Am Heart Assoc 2016
154
6

Caspase-1-induced pyroptotic cell death.
Edward A Miao, Jayant V Rajan, Alan Aderem. Immunol Rev 2011
706
6


Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders.
Hua Jiang, Hongbin He, Yun Chen, Wei Huang, Jinbo Cheng, Jin Ye, Aoli Wang, Jinhui Tao, Chao Wang, Qingsong Liu,[...]. J Exp Med 2017
300
6

Regulation of inflammasome activation.
Si Ming Man, Thirumala-Devi Kanneganti. Immunol Rev 2015
515
6

Metformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent Effects in Diabetic Cardiomyopathy.
Fan Yang, Ying Qin, Yueqiu Wang, Songyan Meng, Huimin Xian, Hui Che, Jie Lv, Yang Li, Yahan Yu, Yunlong Bai,[...]. Int J Biol Sci 2019
123
6

Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation.
Christine Juliana, Teresa Fernandes-Alnemri, Seokwon Kang, Andrew Farias, Fengsong Qin, Emad S Alnemri. J Biol Chem 2012
460
6

Initiation and perpetuation of NLRP3 inflammasome activation and assembly.
Eric I Elliott, Fayyaz S Sutterwala. Immunol Rev 2015
438
6


IL-1β and IL-18: inflammatory markers or mediators of hypertension?
S M Krishnan, C G Sobey, E Latz, A Mansell, G R Drummond. Br J Pharmacol 2014
117
6

The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse.
Eleonora Mezzaroma, Stefano Toldo, Daniela Farkas, Ignacio M Seropian, Benjamin W Van Tassell, Fadi N Salloum, Harsha R Kannan, Angela C Menna, Norbert F Voelkel, Antonio Abbate. Proc Natl Acad Sci U S A 2011
388
6

Pyroptosis: host cell death and inflammation.
Tessa Bergsbaken, Susan L Fink, Brad T Cookson. Nat Rev Microbiol 2009
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.